Skip to main content
MedPathMedPath Home
Clinical Trials/TCTR20230202004
TCTR20230202004
Unknown
Phase 3

The study of effectiveness of platelet-rich plasma (PRP) treatment for lichen planus pigmentosus (pilot study)

Institute of dermatology0 sites15 target enrollmentFebruary 2, 2023
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionsichen planus pigmentosusLichen planus pigmentosusPlatelet-rich plasmaPigmentationMelanin

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
ichen planus pigmentosus
Sponsor
Institute of dermatology
Enrollment
15
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 2, 2023
End Date
May 31, 2023
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Institute of dermatology

Eligibility Criteria

Inclusion Criteria

  • •1\. Patients who were diagnosed with lichen planus pigmentosus, age 18 \- 60 years
  • •2\. Has facial LPP lesion for at least 6 months
  • •3\. Histology confirmed LPP as evidenced by perivascular infiltrate, lichenoid reaction, melanophages and pigment pigmentation (melanin) accumulates under the epidermis and dermis.
  • •4\. Patch test result is negative

Exclusion Criteria

  • •1\. Patients who are pregnant or breastfeeding
  • •2\. Patients with a history of keloids, hypertrophic scars, herpes virus infection or skin disease around the lesion
  • •3\. Patients with blood disorders, liver disease or patients receiving chemotherapy/ anticoagulants
  • •4\. Patients with hyperpigmentation from other conditions, such as pigmented contact dermatitis, with positive patch test results, fixed drug eruption, lichenoid drug reaction, ochronosis, melasma, PIH, endocrinopathies, etc.
  • •5\. Patients with a history of treatment using topical bleaching agents and lasers within 6 months prior to study participation.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Evaluation of the efficacy of platelet-rich plasma in non-infectious diabetic wound healing
IRCT20160803029181N8Shahid Beheshti University of Medical Sciences90
Completed
Phase 2
Efficacy of Platelet Rich Plasma in Wound Healing on Women Undergoing Elective Cesarean Section Surgerywound healing.Disruption of caesarean section wound
IRCT2014041317251N1High Institute for Research and Education in Transfusion Medicine30
Recruiting
Phase 3
Evaluation of the effect of platelet-rich plasma in the treatment of frozen shoulder disease
IRCT20190903044677N2Iranshahr University of Medical Sciences75
Recruiting
Not Applicable
Effect of Platelet-Rich Plasma (PRP) in the treatment of androgenic hair loss
IRCT20160318027097N11Tabriz University of Medical Sciences20
Recruiting
Phase 3
The Efficacy of Platelet-Rich Plasma in the Treatment of Knee Osteoarthritis: a double-blind randomized trial
JPRN-UMIN000016585Department of orthopaedics, Juntendo university80